Market Access & Pricing in Europe

Aims and objectives:

Market access and pricing for drugs  is complex and requires careful preparation for launch. Knowledge of the underlying health systems and the different, mutually influencing pricing systems in Europe is essential for it.

In our online seminar you will receive the most important information for successful market access in the EU4 countries and in the UK.

27th April 2023: Market Access and Pricing in France, Germany and the UK

28th April 2023: Market Access and Pricing in Spain and in Italy

Topics:

- Reference Pricing in Europe
- Payer-Archetyping
- Market Access and Pricing in France, Italy, Spain, Germany and the UK
- Specialties with regard to ATMPs/Gentherapeutics
- HTA process and the role of RWE in the HTA context

Who should attend?

This online seminar is aimed at specialists and executives in the healthcare industry who are involved in market access and pricing in Europe.